BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37702346)

  • 1. Philip Morris International's Formula 1 Sponsorship-Linked Marketing: Transformation From Marlboro to Mission Winnow.
    Dewhirst T; Lee WB; Czaplicki L
    Nicotine Tob Res; 2023 Nov; 25(12):1838-1846. PubMed ID: 37702346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motor racing, tobacco company sponsorship, barcodes and alibi marketing.
    Grant-Braham B; Britton J
    Tob Control; 2012 Nov; 21(6):529-35. PubMed ID: 21821820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Industry marketing of tobacco products on social media: case study of Philip Morris International's IQOS.
    Abroms LC; Wysota CN; Tosakoon S; Khayat A; Duan Z; Bar-Zeev Y; Berg CJ; Levine H
    Tob Control; 2024 Jun; 33(4):518-524. PubMed ID: 36927516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How Philip Morris built Marlboro into a global brand for young adults: implications for international tobacco control.
    Hafez N; Ling PM
    Tob Control; 2005 Aug; 14(4):262-71. PubMed ID: 16046690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cigarette Packs With URLs Leading to Tobacco Company Websites: Content Analysis.
    Weiger CV; Smith K; Hong AY; Cohen JE
    J Med Internet Res; 2020 Jun; 22(6):e15160. PubMed ID: 32459649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncovering Philip Morris International's Fundamental Strategies for Product Placement in Thailand: Spotlighting Industry Penetration to Advance the Endgame.
    Charoenca N; Kungskulniti N; Hamann S; Mock J
    Asian Pac J Cancer Prev; 2021 Dec; 22(12):3789-3801. PubMed ID: 34967557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How Philip Morris unlocked the Japanese cigarette market: lessons for global tobacco control.
    Lambert A; Sargent JD; Glantz SA; Ling PM
    Tob Control; 2004 Dec; 13(4):379-87. PubMed ID: 15564622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA's reduced exposure marketing order for IQOS: why it is not a reliable global model.
    Lempert LK; Bialous S; Glantz S
    Tob Control; 2022 Aug; 31(e1):e83-e87. PubMed ID: 33811155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why Packaging Is Commercially Vital for Tobacco Corporations.
    Barraclough S; Gleeson D
    Asia Pac J Public Health; 2017 Mar; 29(2):132-139. PubMed ID: 28118735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thailand--lighting up a dark market: British American tobacco, sports sponsorship and the circumvention of legislation.
    MacKenzie R; Collin J; Sriwongcharoen K
    J Epidemiol Community Health; 2007 Jan; 61(1):28-33. PubMed ID: 17183011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the Twitter activity around the eighth meeting of the Conference of the Parties to the WHO Framework Convention on Tobacco Control.
    Robertson L; Joshi A; Legg T; Wellock G; Ray K; Evans-Reeves K
    Tob Control; 2022 Jan; 31(1):50-56. PubMed ID: 33177210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corporate social responsibility and the tobacco industry: hope or hype?
    Hirschhorn N
    Tob Control; 2004 Dec; 13(4):447-53. PubMed ID: 15564636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raising generation 'A': a case study of millennial tobacco company marketing in Indonesia.
    Astuti PAS; Assunta M; Freeman B
    Tob Control; 2018 Jul; 27(e1):e41-e49. PubMed ID: 30042229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Virginia Slims identity crisis: an inside look at tobacco industry marketing to women.
    Toll BA; Ling PM
    Tob Control; 2005 Jun; 14(3):172-80. PubMed ID: 15923467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "
    Lagasse LP; Minosa MKR; Moran MB; Cohen JE
    Int J Adolesc Med Health; 2018 Oct; 33(2):. PubMed ID: 30281513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Implications for Tobacco Industry Transformation of the Acquisition of Swedish Match by Philip Morris International.
    Levy DT; Warner KE; Liber AC; Travis N; Sweanor DT; Meza R; Cummings KM
    Nicotine Tob Res; 2023 Nov; 25(12):1899-1903. PubMed ID: 37535864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IQOS: examination of Philip Morris International's claim of reduced exposure.
    St Helen G; Jacob Iii P; Nardone N; Benowitz NL
    Tob Control; 2018 Nov; 27(Suppl 1):s30-s36. PubMed ID: 30158205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promotion of tobacco products on Facebook: policy versus practice.
    Jackler RK; Li VY; Cardiff RAL; Ramamurthi D
    Tob Control; 2019 Jan; 28(1):67-73. PubMed ID: 29622602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Living Tomorrow Project: how Philip Morris has used a Belgian tourist attraction to promote ventilation approaches to the control of second hand smoke.
    Pilkington P; Gilmore AB
    Tob Control; 2004 Dec; 13(4):375-8. PubMed ID: 15564621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heated tobacco product regulation under US law and the FCTC.
    Lempert LK; Glantz SA
    Tob Control; 2018 Nov; 27(Suppl 1):s118-s125. PubMed ID: 30291201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.